Holiday Schedule – Labor/Labour Day
Advarra’s US and Canada offices will be closed all day Monday, September 4, 2023.
Holiday Schedule – Independence Day (US) and Canada Day (CAN)
US offices will be closed/the IRB and IBC will not meet on July 4. Canada offices will be closed/the Canadian REB will not meet on July 3.
Holiday Schedule – Juneteenth National Independence Day (U.S.)
Advarra’s U.S. offices will be closed Monday, June 19, in observance of the Juneteenth holiday. The IRB and IBC will not meet on June 19.
Holiday Schedule – Memorial Day (US)
Due to the upcoming Memorial Day holiday (US), some review timelines and IRB/IBC meeting dates have been modified.
Holiday Schedule – Presidents’ Day (US) and Family Day (Canada)
Due to the upcoming Presidents’ Day holiday (U.S.) and Family Day (Canada), some review timelines and IRB meeting dates have...
Advarra Announces Appointment of Elisa Cascade as Chief Product Officer
Leadership appointment demonstrates Advarra’s commitment to supporting the growth of its technology offerings across the clinical research ecosystem (COLUMBIA, MD.)...
Advarra Announces Appointments of Scott Hoffman as Chief Commercial Officer and Scott Uebele as Chief Operating Officer
Key leadership appointments highlight continued commitment to offering connected solutions across the clinical research ecosystem and providing best-in-class operational delivery to customers
SubjectWell Features Advarra Experts James Riddle and Luke Gelinas in White Paper
In a recent article, SubjectWell interviewed Advarra's James Riddle and Luke Gelinas, Compensation norms create inequity in clinical trials".
Updated Advarra Fee Schedules Now Available
TAdvarra’s updated fee schedules for IRB, IBC, DMC, and EAC are now available. The new fee schedules are effective January 1, 2023.
Winter Holiday Schedule 2022
Advarra’s offices will be closed Monday, December 26, through Monday, January 2, with the exception of our India office locations.
FDA Proposes Revised IRB Regulations, Including Required sIRB for Multisite Trials
The FDA released two proposed rules intended to partially harmonize its current regulations with the Revised Common Rule.
Advarra Achieves 1,000+ Site Milestone for its Gene Therapy Ready Network
Research involving gene therapy-based treatments can start more quickly with Advarra’s growing network of registered research sites.